Microbial production of nicotamide riboside
AssigneeDsm IP Assets B.V.
InventorsAdam G. Lawrence, Celine ViArouge
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a novel method, expression vectors, and host cells for producing nicotinamide riboside by regulating the pathways that lead to the production of nicotinamide riboside.
Claims3
A method for producing nicotinamide riboside (NR), comprising culturing a bacterium cell in a medium under conditions effective to produce NR and recovering NR from the medium and thereby producing NR, wherein the bacterium cell comprises the modification of adding the activity of a heterologous nicotinic acid amidating protein (NadE*) and further comprises at least one modification selected from the group consisting of:
- a) adding or increasing the activity of a nicotinamide adenine dinucleotide (NAD+) hydrolyzing protein;
- b) blocking or reducing the activity of a protein which functions to repress NAD+ biosynthesis by repressing transcription of nadA, nadB, nadC genes or combinations thereof;
- c) blocking or reducing the activity of a protein which functions as a nicotinamide riboside transporter protein;
- d) blocking or reducing the activity of a protein which functions as a nicotinic acid mononucleotide adenyltransferase;
- e) blocking or reducing the activity of a protein which functions as a nicotinamide mononucleotide amidohydrolase;
- f) blocking or reducing the activity of a protein which functions as a purine nucleoside phosphorylase;
- g) adding or increasing the activity of a protein which functions as a nicotinamide mononucleotide hydrolase;
- and
- h) adding or increasing the activity of a protein which functions as a L-aspartate oxidase, a quinolate synthase, a quinolate phosphoribosyltransferase, or combinations thereof.
A method for producing nicotinamide riboside (NR), comprising culturing a bacterium cell in a medium under conditions effective to produce NR and recovering NR from the medium and thereby producing NR, wherein the bacterium cell comprises the modification of adding the activity of a heterologous nicotinic acid amidating protein (NadE*) and the modification of:
- adding or increasing the activity of a nicotinamide adenine dinucleotide (NAD+) hydrolyzing protein.
Dependencies are inferred from the claim text.